UPDATE : Friday, June 5, 2020
Drugmaker cancels event for 1,000 doctors due to new coronavirus risk by Park Gi-taek 2020-01-29 15:51
‘Dupixent revolutionary atopic dermatitis drug to end lack of fundamental treatment’ by Kim Yun-mi 2020-01-29 14:00
Afstyla wins nod as new therapy for hemophilia A by Kim Yun-mi 2020-01-24 08:18
MIT promotes industrial liaison program to Korean drugmakers by Jeong Sae-im 2020-01-23 12:04
'Reimbursement for Repatha to expand treatment options for ASCVD patients' by Lee Han-soo 2020-01-22 15:14
Sales of antidiabetic SGLT-2 inhibitors grew 40% in 2019 by Kim Yun-mi 2020-01-22 15:10
HanAll remains positive of eye treatment’s efficacy despite initial failure by Lee Han-soo 2020-01-21 15:12
SK Biopharma’s US partner gets EMA nod for sleepiness treatment by Lee Han-soo 2020-01-21 14:22
Some Merck Korea workers commute from provinces to Seoul every day by Kim Yun-mi 2020-01-21 14:21
Daewoong’s Jeuveau sold ₩40 billion in US in 8 months by Jeong Sae-im 2020-01-21 11:43
CoImmune acquires Formula Pharmaceuticals by Lee Han-soo 2020-01-20 15:45
Pfizer’s spinoff of generics unit causes disputes with trade union by Kim Yun-mi 2020-01-20 15:44
Korea’s botulinum toxin exports hit record high in 2019 by Jeong Sae-im 2020-01-20 11:38
Takeda’s Kynteles expands indication for ulcerative colitis, Crohn’s disease by Kim Yun-mi 2020-01-17 17:30
GenScript to market Genopis' GMP-grade plasmid DNA by Lee Han-soo 2020-01-17 17:28
AbbVie says its psoriasis drug superior to Novartis’ treatment by Lee Han-soo 2020-01-17 17:28
HanAll, Daewoong unveil P3 topline results for dry eye treatment by Lee Han-soo 2020-01-16 15:46
Genome to conduct immunotherapy combo trial with Merck, Pfizer by Lee Han-soo 2020-01-16 14:47
GSK to target ovarian cancer, multiple myeloma, endometrial cancer by Kim Yun-mi 2020-01-16 14:10
Sweden prolongs financial support for IVI’s vaccine development by Lee Han-soo 2020-01-16 10:45
Back to Top